VEGFA and neoplasm: Since 5-FU can selectively kill MDSCs and enhance T-lymphocyte-mediated antitumor immune responses [17], we evaluated the effect of 5-FU and the clinically available prodrug of 5-FU, capecitabine, on LLC tumor growth under anti-VEGF treatment.